ANNA GREKA, M.D.
Osteopathic Medicine at Fruit St, Boston, MA
License number
Massachusetts 230247
Category
Osteopathic Medicine
Type
Nephrology
License number
Massachusetts 230247
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
55 Fruit St #STREET10, Boston, MA 02114
285 Brush Hill Rd, Milton, MA 02186
285 Brush Hill Rd, Milton, MA 02186
Phone
(617) 726-5050
(617) 726-4900
(617) 726-4900
Personal information
See more information about ANNA GREKA at radaris.comName
Address
Phone
285 Brush Hill Rd, Milton, MA 02186
201 Newbury St, Boston, MA 02116
285 Brush Hill Rd, Milton, MA 02186
44 Browne St, Brookline, MA 02446
44 Browne St, Brookline, MA 02446
Organization information
See more information about ANNA GREKA at bizstanding.comAnna Greka MD,PHD
165 Cambridge St, Boston, MA 02114
Industry:
Internist
Phone:
(617) 726-5050 (Phone)
Anna Greka
Professional information
See more information about ANNA GREKA at trustoria.com
Anna Greka, Boston MA
Anna Greka, Boston MA
Specialties:
Internist
Address:
165 Cambridge St, Boston, MA 02114
55 Fruit St, Boston, MA 02114
55 Fruit St, Boston, MA 02114
Education:
Doctor of Medicine
Massachusetts General Hospital - Fellowship - Nephrology (Internal Medicine)
Massachusetts General Hospital - Residency - Internal Medicine
Massachusetts General Hospital - Internship - Internal Medicine
Massachusetts General Hospital - Fellowship - Nephrology (Internal Medicine)
Massachusetts General Hospital - Residency - Internal Medicine
Massachusetts General Hospital - Internship - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
Methods Of Treating Kidney Disease
Methods Of Treating Kidney Disease
US Patent:
2011013, Jun 9, 2011
Filed:
Nov 16, 2010
Appl. No.:
12/947574
Inventors:
ANNA GREKA - Milton MA, US
International Classification:
A61K 49/00, A61K 39/395, A61K 39/00, A61K 31/713, A61P 13/12, G01N 33/53
US Classification:
424 92, 4241301, 4241841, 514 44 A, 435 721
Abstract:
It has been discovered that TRPC5 activity abolishes actin stress fibers and diminishes focal adhesion formation, rendering a motile, migratory podocyte phenotype. This invention relates generally to methods of reducing expression or activity of TRPC5 to treat, or reduce risk of developing, kidney disease, e.g., proteinuria, in a subject.